Tumor Regression Grade as a Predictor of Adjuvant Therapy Benefits in Esophageal Squamous Cell Carcinoma Patients After Neoadjuvant Therapy
TRG is a promising predictor of the prognostic value of adjuvant therapy in ESCC patients. Patients with a good TRG response, positive lymph nodes, and ypT3-4 stage benefit from adjuvant therapy.
Authors
- Bingqiang Cai
- Yongcong Zhang (ORCID: https://orcid.org/0009-0009-1254-6549)
- Yizhou Huang (ORCID: https://orcid.org/0000-0002-5523-4360)
- Maohui Chen (ORCID: https://orcid.org/0000-0002-2064-8715)
- Taidui Zeng (ORCID: https://orcid.org/0000-0001-8602-8909)
- Chun Chen (ORCID: https://orcid.org/0000-0001-9264-8020)
- Bin Zheng (ORCID: https://orcid.org/0000-0001-8429-5384)
- Chuanquan Lin
- Shuliang Zhang (ORCID: https://orcid.org/0000-0003-2320-7912)
- Yuanpu Wei
Institutions
- Fujian Medical University (CN)
- First Affiliated Hospital of Xiamen University (CN)
- The 180th Hospital of PLA (CN)
- Fujian Provincial Cancer Hospital (CN)
- Affiliated Hangzhou First People's Hospital, Westlake University, School of Medicine (CN)
- Union Hospital (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- Cancer Medicine
- Published
- 2025-09-01
- DOI
- https://doi.org/10.1002/cam4.71166
- Citations
- 1
- Primary Topic
- Esophageal Cancer Research and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.01